Synergistic Effects of Resveratrol and Temozolomide Against Glioblastoma Cells: Underlying Mechanism and Therapeutic Implications

Synergistic Effects of Resveratrol and Temozolomide Against Glioblastoma Cells: Underlying Mechanism and Therapeutic Implications

Yusi Liu, Xue Song, Moli Wu, Jiao Wu, Jia Liu Liaoning Laboratory of Cancer Genetics and Epigenetics and Department of Cell Biology, College of Basic Medical Sciences, Dalian Medical University, Dalian, People’s Republic of ChinaCorrespondence: Jia LiuLiaoning Laboratory of Cancer Genetics...

Full description

Bibliographic Details
Main Authors:	Liu Y, Song X, Wu M, Wu J, Liu J
Format:	Article
Language:	English
Published:	Dove Medical Press 2020-09-01
Series:	Cancer Management and Research
Subjects:	resveratrol temozolomide synergistic effects glioblastoma mgmt stat3 bcl-2 survivin
Online Access:	https://www.dovepress.com/synergistic-effects-of-resveratrol-and-temozolomide-against-glioblasto-peer-reviewed-article-CMAR

Similar Items

Retinoblastoma Binding Protein 4 Modulates Temozolomide Sensitivity in Glioblastoma by Regulating DNA Repair Proteins
by: Gaspar J. Kitange, et al.
Published: (2016-03-01)

A Novel DNA Methylation-Based Signature Can Predict the Responses of MGMT Promoter Unmethylated Glioblastomas to Temozolomide
by: Rui-Chao Chai, et al.
Published: (2019-09-01)

Levetiracetam enhances the temozolomide effect on glioblastoma stem cell proliferation and apoptosis
by: Bianca Maria Scicchitano, et al.
Published: (2018-09-01)

Senescence Is the Main Trait Induced by Temozolomide in Glioblastoma Cells
by: Beltzig, L., et al.
Published: (2022)

Mifepristone Overcomes Tumor Resistance to Temozolomide Associated with DNA Damage Repair and Apoptosis in an Orthotopic Model of Glioblastoma
by: Monserrat Llaguno-Munive, et al.
Published: (2018-12-01)

MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy
by: Melguizo Consolación, et al.
Published: (2012-12-01)

Effects of Long-Term Temozolomide Treatment on Glioblastoma and Astrocytoma WHO Grade 4 Stem-Like Cells
by: Brandner, S., et al.
Published: (2022)

Hedgehog/Gli1 signaling pathway regulates MGMT expression and chemoresistance to temozolomide in human glioblastoma
by: Ke Wang, et al.
Published: (2017-12-01)

Efficacy of Whole-Ventricular Radiotherapy in Patients Undergoing Maximal Tumor Resection for Glioblastomas Involving the Ventricle
by: Kyung Hwan Kim, et al.
Published: (2021-09-01)

Prognostic significance of IDH-1 and MGMT in patients with glioblastoma: One step forward, and one step back?
by: Combs Stephanie E, et al.
Published: (2011-09-01)

Glioblastoma and the significance of MGMT gene methylation
by: Payam Izadpanahi, et al.
Published: (2014-08-01)

Treatment options and outcomes for glioblastoma in the elderly patient
by: Arvold ND, et al.
Published: (2014-02-01)

Gossypol Suppresses Growth of Temozolomide-Resistant Glioblastoma Tumor Spheres
by: Hee Yeon Kim, et al.
Published: (2019-10-01)

Combination chemoradiotherapy with temozolomide, vincristine, and interferon-β might improve outcomes regardless of O6-methyl-guanine-DNA-methyltransferase (MGMT) promoter methylation status in newly glioblastoma
by: Kenichiro Asano, et al.
Published: (2021-07-01)

Temozolomide Induced Hypermutation in Glioma: Evolutionary Mechanisms and Therapeutic Opportunities
by: Paul Daniel, et al.
Published: (2019-02-01)

Synergistic Induction of Erlotinib-Mediated Apoptosis by Resveratrol in Human Non-Small-Cell Lung Cancer Cells by Down-Regulating Survivin and Up-Regulating PUMA
by: Peipei Nie, et al.
Published: (2015-04-01)

Looking for A Place for Dose-Dense TMZ Regimens in GBM Patients: An Experience with MGMT Exploratory Evaluation
by: Luca Napoleoni, et al.
Published: (2019-01-01)

The Impact of <i>MGMT</i> Promoter Methylation and Temozolomide Treatment in Serbian Patients with Primary Glioblastoma
by: Nikola Jovanović, et al.
Published: (2019-02-01)

Prognostic genetic markers in malignant gliomas
by: Ralf Ketter, et al.
Published: (2010-12-01)

Temozolomide in aggressive pituitary adenomas and carcinomas
by: Leon D. Ortiz, et al.
Published: (2012-01-01)

The Impact of Surgery in IDH 1 Wild Type Glioblastoma in Relation With the MGMT Deregulation
by: Francesco Marchi, et al.
Published: (2020-01-01)

A ”Clickable” Probe for Active MGMT in Glioblastoma Demonstrates Two Discrete Populations of MGMT
by: Sudhir Raghavan, et al.
Published: (2020-02-01)

The interaction between TERT promoter mutation and MGMT promoter methylation on overall survival of glioma patients: a meta-analysis
by: Huy Gia Vuong, et al.
Published: (2020-09-01)

Quinacrine enhances temozolomide cytotoxicity in temozolomide-sensitive and -resistant glioblastoma cells
by: Pingde Zhang, et al.
Published: (2018-01-01)

Molecular Mechanisms of KDELC2 on Glioblastoma Tumorigenesis and Temozolomide Resistance
by: Yu-Ling Tsai, et al.
Published: (2020-09-01)

Glioblastoma management: challenges in the elderly population
by: Niranjan Tachamo, et al.
Published: (2016-10-01)

Integrins and p53 pathways in glioblastoma resistance to temozolomide
by: Monique eDontenwill, et al.
Published: (2012-10-01)

Aspergillosis in a Patient Receiving Temozolomide for the Treatment of Glioblastoma
by: Rodrigo Ramella Munhoz, et al.
Published: (2013-08-01)

The Synergistic Effects of the Combination of Ciprofloxacin and Temozolomide on Human Glioblastoma A-172 Cell Line
by: Ashkan Zandi, et al.
Published: (2017-01-01)

Piperine synergistically enhances the effect of temozolomide against temozolomide-resistant human glioma cell lines
by: Somi Jeong, et al.
Published: (2020-01-01)

Meningeal seeding from glioblastoma multiforme treated with radiotherapy and temozolomide
by: Lu-Ting Kuo, et al.
Published: (2017-01-01)

A phase II open label, randomised study of ipilimumab with temozolomide versus temozolomide alone after surgery and chemoradiotherapy in patients with recently diagnosed glioblastoma: the Ipi-Glio trial protocol
by: Nicholas F. Brown, et al.
Published: (2020-03-01)

Strategies of temozolomide in future glioblastoma treatment
by: Lee CY
Published: (2017-01-01)

Postoperative resveratrol administration improves prognosis of rat orthotopic glioblastomas
by: Xue Song, et al.
Published: (2018-09-01)

Histone 2A Family Member J Drives Mesenchymal Transition and Temozolomide Resistance in Glioblastoma Multiforme
by: Hsun-Hua Lee, et al.
Published: (2019-12-01)

Revisiting the Immunological Aspects of Temozolomide Considering the Genetic Landscape and the Immune Microenvironment Composition of Glioblastoma
by: Natalia Di Ianni, et al.
Published: (2021-09-01)

Considering the Experimental use of Temozolomide in Glioblastoma Research
by: Verena J. Herbener, et al.
Published: (2020-06-01)

Radiotherapy with or without temozolomide in elderly patients aged ≥ 70 years with glioblastoma
by: Evrim Metcalfe, et al.
Published: (2016-08-01)

Identifying Predictive Gene Expression and Signature Related to Temozolomide Sensitivity of Glioblastomas
by: Hong-Qing Cai, et al.
Published: (2020-05-01)

Upfront Bevacizumab and Temozolomide or Fotemustine before Radiotherapy for Patients with Glioblastoma and Severe Neurological Impairment at Diagnosis
by: Celina Bihan, et al.
Published: (2012-09-01)

Cannot write session to /tmp/vufind_sessions/sess_qcn2fn940p9ejp0ff4o43sgljt